A large-scale, multi-center study of 411 transplants for children with high-risk acute lymphoblastic leukemia (ALL) has shown comparable transplant outcomes with sibling and unrelated donors. Median age of patients was 10.1 years (range, 0.5-18.5), and all patients were conditioned with total-body irradiation and etoposide during first or subsequent remissions. Grafts were from HLA-identical siblings (n=105) or from 9/10 or 10/10 HLA-matched unrelated donors (n=306). At a median follow-up of 4.2 years, 4-year event-free survival was comparable in unrelated and sibling donor transplants: 67% vs. 71%, respectively, (p=0.405).
Choose a Topic
- All Topics
- Patient Eligibility
- AML
- Unrelated Donor HCT
- Post-Transplant
- CIBMTR Publications
- GVHD
- ALL
- Lymphomas and CLL
- Preparative Regimens
- Pediatric HCT
- Older Patient HCT
- MDS
- Non-Malignant Disorders
- BMT CTN Publications
- Cord Blood
- Multiple Myeloma
- Sickle Cell Disease
- HLA Matching
- ASH 2015
- ASH 2017
- ASH 2016
- ASH 2020
- CML
- ASH 2018
- Neuroblastoma
Related, Unrelated HCT Outcomes Comparable in Pediatric ALL
Mar 2015